EMC Instytut Medyczny SA (EMC):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:EMC Instytut Medyczny SA (EMC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82207FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

EMC Instytut Medyczny SA (EMC Instytut) is a health care service provider. The organization provides medical and patient care services. It offers services, such as medical packages, inpatient treatment, diagnostics, specialist consultations, primary health care, outpatient rehabilitation, 24h medical europaservice, and selected healthcare services. EMC Instytut provides hospitalization services in the field of general surgery, surgical oncology, plastic surgery, maxillo-facial surgery, internal diseases, gastroenterology, geriatrics, gynecology, neonatology, orthopedics, obstetrics, pediatrics, rehabilitation, laryngology, hospital emergency, and neurotic disorders. It has hospitals, outpatient specialty and primary care clinics. EMC is headquartered in Wroclaw, Silesia, Poland.

EMC Instytut Medyczny SA Key Recent Developments

Dec 10, 2013: EMC Instytut Medyczny Group revenue for the third quarter of 2013 increased 14.7 percent to PLN 44.5 million
May 21, 2013: The Group EMC Instytut Medyczny reports improved First Quarter Results 2013
Mar 22, 2013: The EMC Capital Group has improved its financial performance in 2012 year-on-year

This comprehensive SWOT profile of EMC Instytut Medyczny SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of EMC Instytut Medyczny SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

EMC Instytut Medyczny SA – Key Information
EMC Instytut Medyczny SA – Overview
EMC Instytut Medyczny SA – Key Employees
EMC Instytut Medyczny SA – Key Employee Biographies
EMC Instytut Medyczny SA – Key Operational Heads
EMC Instytut Medyczny SA – Major Products and Services
EMC Instytut Medyczny SA – History
EMC Instytut Medyczny SA – Company Statement
EMC Instytut Medyczny SA – Locations And Subsidiaries
EMC Instytut Medyczny SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

EMC Instytut Medyczny SA – Business Description
EMC Instytut Medyczny SA – Corporate Strategy
EMC Instytut Medyczny SA – SWOT Analysis
SWOT Analysis – Overview
EMC Instytut Medyczny SA – Strengths
EMC Instytut Medyczny SA – Weaknesses
EMC Instytut Medyczny SA – Opportunities
EMC Instytut Medyczny SA – Threats
EMC Instytut Medyczny SA – Key Competitors

Section 3 – Company Financial Performance Charts

EMC Instytut Medyczny SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

EMC Instytut Medyczny SA, Key Information
EMC Instytut Medyczny SA, Key Ratios
EMC Instytut Medyczny SA, Share Data
EMC Instytut Medyczny SA, Major Products and Services
EMC Instytut Medyczny SA, History
EMC Instytut Medyczny SA, Key Employees
EMC Instytut Medyczny SA, Key Employee Biographies
EMC Instytut Medyczny SA, Key Operational Heads
EMC Instytut Medyczny SA, Other Locations
EMC Instytut Medyczny SA, Subsidiaries
EMC Instytut Medyczny SA, Key Manufacturing facilities
EMC Instytut Medyczny SA, Key Competitors
EMC Instytut Medyczny SA, SWOT Analysis
EMC Instytut Medyczny SA, Ratios based on current share price
EMC Instytut Medyczny SA, Annual Ratios
EMC Instytut Medyczny SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

EMC Instytut Medyczny SA, Performance Chart
EMC Instytut Medyczny SA, Ratio Charts

★海外企業調査レポート[EMC Instytut Medyczny SA (EMC):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Energi Mega Persada Tbk:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PT Energi Mega Persada Tbk Merg …
  • Scancell Holdings Plc (SCLP):企業財務及び戦略的SWOT分析
    Summary Scancell Holdings Plc (Scancell) is a pharmaceutical company that manufactures and markets cancer treatment products. The company offers SCIB1, a cancer vaccine that is used in the treatment of melanoma. Its product stimulates immune responses to the lung cancer antigen NY-ESO-1. Its SCIB2 s …
  • HealthSouth Corporation (HLS):企業概要、財務及び戦略的SWOT分析
    Summary HealthSouth Corporation (HealthSouth) is a healthcare service provider. The company owns and operates inpatient rehabilitation and hospitals to provides healthcare and medical care services. Its services consist of treatment to medical conditions such as brain injury, cardiac care, diabetes, …
  • Dart Energy Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Dart Energy Limited Mergers and …
  • Bloomberg, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bloomberg, Inc. Mergers and Acq …
  • Dulas Ltd:企業のM&A・提携動向(発電分野)
    Summary Dulas Ltd (Dulas) is a renewable energy company that offers hydro, biomass, solar and wind energy solutions. The company’s products include solar PV systems and solar refrigeration systems. Its wind energy development services include feasibility, site finding, resource assessment, wind moni …
  • The National Fostering Agency:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The National Fostering Agency M …
  • EDF Energy Holdings Ltd:発電所・企業SWOT分析
    EDF Energy Holdings Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • China Hi-Tech Group Co. Ltd. (600730):企業財務及び戦略的SWOT分析
    Summary China Hi-Tech Group Co. Ltd. (China Hi-Tech), formerly China Hi-Tech Group Company is a diversified company that offers development strategy, education, commodity trading, investment property and asset management. Its asset management services includes use of financial investment and strateg …
  • Oranje-Nassau Energie B.V.:企業のM&A・提携動向(石油・ガス分野)
    Summary Oranje-Nassau Energie B.V. (ONE) is an upstream oil and gas company that acquires, develops, explores for and produces oil and natural gas. The company focuses on assets in the North Sea Ventures in the Netherlands and the UK. It also has assets in Kowe Block and Agali Block in Gabon. ONE ac …
  • Financierings-Maatschappij Voor Ontwikkelingslanden N.V.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Financierings-Maatschappij Voor …
  • Duke Energy Florida, Inc.:企業のM&A・提携動向(エネルギー分野)
    Summary Duke Energy Florida, Inc. (Duke Energy Florida), formerly Progress Energy Florida, Inc., a subsidiary of Duke Energy Corporation, is a regulated public utility company. It carries out activities related to generation, transmission, distribution and sale of electricity in Florida. The company …
  • AFFiRiS AG:企業のM&A・提携動向(医療分野)
    Summary AFFiRiS AG (AFFiRiS) is a biotechnology company that develops and manufactures novel synthetic vaccines against chronic diseases. It develops customized peptide vaccines based on its proprietary AFFITOME technology for the prevention of Alzheimer's disease, Parkinson's disease, atheroscleros …
  • DAIICHI SANKYO, INC.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DAIICHI SANKYO, INC. Mergers an …
  • Zurich Insurance Company South Africa Limited:企業の戦略・SWOT・財務分析
    SummaryZurich Insurance Company South Africa Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ vi …
  • Petsec Energy Limited (PSA):企業の財務及び戦略的SWOT分析
    Summary Petsec Energy Limited (Petsec) is an independent oil and gas exploration and production company that carries out the acquisition, exploration, development and production of oil and gas assets. The company’s operations include Producing Leases, Exploration Leases and Shale Oil. Petsec through …
  • Rigel Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rigel Pharmaceuticals, Inc. Mer …
  • Melco Holdings Inc. (6676):企業財務及び戦略的SWOT分析
    Summary Melco Holdings Inc. (Melco Holdings) is a technology company that manufactures and sells memory storage devices. The company provides memory products, storage products, network and broadband products, digital home products, supplies and accessories, and DOS/V parts. Its memory products inclu …
  • Pembina Pipeline Corporation (PPL):企業財務及び戦略的SWOT分析
    Summary Pembina Pipeline Corporation (Pembina) is a provider of transportation and midstream services. It owns and operates an integrated system of pipelines which transport various hydrocarbon liquids including conventional and synthetic crude oil, heavy oil and oil sands products. The company offe …
  • Agilent Technologies, Inc. (A):企業のM&A・提携動向(医療機器分野)
    Summary Agilent Technologies, Inc. (Agilent) is a provider of instruments, reagents, software, services and consumables to diagnostics, life sciences and applied chemical markets for comprehensive laboratory workflow. The company offers its products to biotechnology, pharmaceutical, CRO and CMO, che …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆